Jean-Paul Feugeas Selected Research

Autophagy-Related Protein 8 Family

9/2021

GABARAPL1 Inhibits EMT Signaling through SMAD-Tageted Negative Feedback.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Paul Feugeas Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 03/2007
6	Breast Neoplasms (Breast Cancer) 05/2020 - 03/2007
4	Renal Cell Carcinoma (Grawitz Tumor) 04/2022 - 04/2010
4	Melanoma (Melanoma, Malignant) 03/2019 - 01/2016
3	Hypoxia (Hypoxemia) 05/2017 - 04/2010
3	Neoplasm Metastasis (Metastasis) 01/2016 - 04/2010
2	Brain Neoplasms (Brain Tumor) 05/2020 - 06/2017
2	Triple Negative Breast Neoplasms 11/2019 - 06/2017
2	Necrosis 11/2019 - 02/2015
2	Carcinoma (Carcinomatosis) 01/2019 - 04/2010
2	Autism Spectrum Disorder 01/2019 - 01/2015
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2015
2	Critical Illness (Critically Ill) 08/2011 - 05/2008
1	Heart Failure 01/2022
1	Iron Deficiencies 01/2022
1	Adenocarcinoma of Lung 09/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Lung Neoplasms (Lung Cancer) 12/2020
1	Carcinogenesis 12/2019
1	Rheumatoid Arthritis 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2015
1	Kidney Neoplasms (Kidney Cancer) 02/2015
1	Dysbiosis 01/2015
1	Respiratory Insufficiency (Respiratory Failure) 05/2008
1	Ketosis 10/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2007
3	Messenger RNA (mRNA)IBA 03/2019 - 04/2010
3	Biomarkers (Surrogate Marker)IBA 03/2019 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2019 - 01/2016
2	EnzymesIBA 12/2020 - 12/2019
2	AngiopoietinsIBA 05/2020 - 04/2010
2	dectin 1IBA 01/2019 - 01/2015
2	Biological ProductsIBA 01/2019 - 10/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	IronIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 09/2021
1	Autophagy-Related Protein 8 FamilyIBA 09/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 05/2020
1	Peptides (Polypeptides)IBA 11/2019
1	cabozantinibIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 05/2017
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2015
1	MicroRNAs (MicroRNA)IBA 06/2015
1	Sunitinib (Sutent)FDA Link 02/2015
1	Therapeutic UsesIBA 02/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Hormones (Hormone)IBA 11/2014
1	Cytotoxins (Cytolysins)IBA 01/2014
1	Phenobarbital (Luminal)FDA Link 03/2013
1	ProcalcitoninIBA 08/2011
1	pro-brain natriuretic peptide (1-76)IBA 05/2008
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2008
1	Epirubicin (Ellence)FDA LinkGeneric 03/2007
1	Keratins (Keratin)IBA 03/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2007
1	Bicarbonates (Hydrogen Carbonate)IBA 10/2004
1	Ketone BodiesIBA 10/2004
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 10/2004
1	acetoacetic acid (acetoacetate)IBA 10/2004
1	ElectrolytesIBA 10/2004

Therapy/Procedure

4	Lasers (Laser) 01/2019 - 06/2015
3	Drug Therapy (Chemotherapy) 05/2017 - 03/2007
2	Therapeutics 03/2019 - 01/2016
1	Immunotherapy 04/2022
1	Adjuvant Chemotherapy 01/2022
1	Transplantation 01/2016
1	Ovariectomy (Oophorectomy) 11/2014
1	Neoadjuvant Therapy 03/2007